Paulo Ricardo Centeno Rodrigues

Paulo Ricardo Centeno Rodrigues

Auto-generated profile, based on publicly available information

Paulo Ricardo Centeno Rodrigues

Universidade Federal de Pelotas

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2024 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
CBCarolina Litchina Brasil
Carolina Litchina Brasil
VGVitória Sequeira Gonçalves
Vitória Sequeira Gonçalves
FSFrancisco Denis Souza Santos
Francisco Denis Souza Santos
PRPaulo Ricardo Centeno Rodrigues
Paulo Ricardo Centeno Rodrigues
FLFabio Leite
Fabio Leite
DPDaniela Brayer Pereira
Daniela Brayer Pereira

30 September 2019 in Semina: Ciências Agrárias
Verified
Journal Article
Open access
PDF file
MLMatheus Lopes
Matheus Lopes
JDJosé Dominguez
José Dominguez
CPCristina Peter
Cristina Peter
ESEderson Santos
Ederson Santos
PRPaula Rodrigues
Paula Rodrigues
GFGeferson Fischer
Geferson Fischer
The aim of this study was to evaluate the humoral immune response in beef heifers supplemented with mineral supplementation with or without the addition of rumen-protected methionine. Forty-eight Brangus nulliparous heifers were distributed into four experimental groups with three replications each: control group without supplementation and without vaccination (CG01), control group without supplementation and with vaccination (CG02), treatment group with mineral supplementation and vaccination (TG01), and treatment group with mineral supplementation added with protected methionine and vaccination (TG02). The animals were maintained under native pasture with access to water ad libitum and the supplementation was available in high-consumption covered troughs. A supplementation period of 60 days prior to vaccinations was adopted until the first dose of a monovalent experimental vaccine inactivated for BoHV-5 was applied as a method of stimulating the immune response to evaluate the supplementation effects. After a 21-day interval, blood samples were collected to evaluate the humoral response and the second vaccine booster dose was applied following the 21-day interval for new blood samples in order to evaluate the immune response against the two-vaccination protocol. From the beginning of the experiment, the animals were weighed on the days ?60, ?10, 0, 21, and 42 in relation to the vaccine protocol. The experimental groups did not differ for body weight, mean daily weight gain, and body condition score after 102 days of supplementation regardless of the treatment. No animals belonging to CG01 seroconverted throughout the experiment, proving that there was no introduction of the agent (BoHV) in the studied area. When vaccinated animals were compared to the CG01 control group, statistically higher levels of neutralizing antibodies (P ? 0.0001) and IgG (P ? 0.0001) were verified 21 days after the second vaccine dose. Among the animals of the three vaccinated groups, there was no difference in seroconversion and IgG production. Therefore, no benefits of mineral supplementation or enriched with protected methionine were observed for the humoral immune response of the studied animals.

27 March 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
Nadálin Yandra BottonNadálin Yandra Botton
Nadálin Yandra Botton
CFCarla Patrícia de Freitas
Carla Patrícia de Freitas
CPCristina Peter
Cristina Peter
LBLariane da Silva Barcelos
Lariane da Silva Barcelos
Leonardo Clasen RibeiroLeonardo Clasen Ribeiro
Leonardo Clasen Ribeiro
GFGeferson Fischer
Geferson Fischer
O sistema imune presente nas mucosas representa a barreira inicial frente à infecção por diversos patógenos que utilizam estas superfícies como porta de entrada no organismo hospedeiro, como é o caso dos Alphaherpesvirus bovino 1 (BoHV-1) e Alphaherpesvirus bovino 5 (BoHV-5). Estes vírus infectam os sistemas reprodutivo e respiratório de bovinos e são responsáveis por casos de Rinotraqueíte Infecciosa Bovina, Vulvovaginite Pustular Infecciosa e Balanopostite Pustular Infecciosa, assim como Meningoencefalite Herpética Bovina, respectivamente. A infecção pelos BoHVs ocorre nas cavidades revestidas por células epiteliais de mucosa, principalmente nasal e genital, sendo o ponto inicial de replicação, seguindo-se a disseminação local, viremia eventual e disseminação neuronal, até o estabelecimento da latência. A cooperação dos mecanismos de defesa confere proteção através do sistema integrado de mucosas por meio da ativação dos sítios efetores e especialmente produção de diferentes isotipos de imunoglobulinas, como a SIgA, realiza neutralização nas superfícies mucosas, e a IgG, que desempenha neutralização na mucosa e sistemicamente. A indução da imunidade nas superfícies mucosas através do uso de vacinas torna-se de extrema importância para a prevenção da adsorção do vírus à célula e infecção pelos microrganismos patogênicos e depende, especialmente, do imunógeno, via de imunização e substância adjuvante empregada nas formulações. Esta revisão teve como objetivo abordar os principais aspectos relacionados à infecção pelo BoHV-1 e BoHV-5, assim como os tipos de resposta relacionadas ao sistema imune de mucosas frente a estes vírus e, ainda, estudos relacionados à utilização das vias mucosas para administração de vacinas em diferentes espécies animais.

1 May 2020 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
PDF file
PRP.R.C. Rodrigues
P.R.C. Rodrigues
RCRodrigo Cunha
Rodrigo Cunha
FSF.D.S. Santos
F.D.S. Santos
VGV.S. Gonçalves
V.S. Gonçalves
PAP.M.M. Albuquerque
P.M.M. Albuquerque
FLFabio Leite
Fabio Leite
RESUMO O herpesvírus equídeo 1 (EHV-1) apresenta distribuição mundial e causa graves prejuízos à equideocultura. É agente de surtos de doença respiratória, reprodutiva e neurológica, em equídeos jovens e adultos. A glicoproteína D (gD) do envelope viral é essencial para ligação e penetração em células permissivas e direcionamento do sistema imunológico do hospedeiro, induz respostas imunes humorais e celulares, sendo um antígeno apropriado para ser utilizado em vacinas e imunodiagnóstico. O objetivo deste trabalho foi expressar e caracterizar a gD do EHV-1 em Pichia pastoris para posterior utilização como antígeno em técnicas de imunodiagnóstico e formulação de vacinas recombinantes. Uma sequência de DNA que codifica uma forma truncada da gDEHV-1 foi clonada no vetor pPICZαA de expressão em P. pastoris. Obteve-se uma proteína de ~41 kDa, como esperado. A proteína apresentou glicosilação entre 4 kDa e 16 kDa, demonstrada por deglicosilação enzimática. A proteína recombinante foi caracterizada antigenicamente e imunogenicamente por Western blot, utilizando-se anticorpos policlonais equinos anti-EHV-1, e por ELISA indireto em modelo murino, demonstrando que a gD recombinante manteve epítopos similares aos da proteína nativa. Esses resultados sugerem que a gDEHV-1 é um antígeno promissor para uso como imunobiológico no controle do EHV-1.

7 November 2023 in Brazilian Journal of Veterinary Research and Animal Science
Verified
Journal Article
Open access
PDF file
MMMariana Andrade Mousquer
Mariana Andrade Mousquer
BMBruna dos Santos Suñe Moraes
Bruna dos Santos Suñe Moraes
ASAlice Corrêa Santos
Alice Corrêa Santos
RSRafaela Pinto de Souza
Rafaela Pinto de Souza
MLMarcelo de Lima
Marcelo de Lima
CNCarlos Eduardo Wayne Nogueira
Carlos Eduardo Wayne Nogueira
Both pregnancy and obesity can influence significant changes in the immune system. On this basis, the present study proposes to evaluate the humoral immune response of overweight pregnant mares in response to a commercial vaccine. Thirty pregnant Crioulo mares were separated according to body condition score (BCS) into overweight (BCS≥7/9) or lean-control (BCS= 5-6/9). In each group, the animals were subdivided into vaccinated and controls. The mares were vaccinated against EHV-1 in two doses spaced 21 days apart and had their blood collected monthly, for five months, for antibody evaluation. Both vaccinated groups had an increase in specific neutralizing antibodies after the vaccine. However, after the second dose, there was no increase in antibodies in any of the groups. Vaccinated overweight and lean-control mares did not differ at any time point. Therefore, this study demonstrated that obesity does not influence the humoral immune response in pregnant Crioulo mares.

1 January 2023 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
MMMariana Andrade Mousquer
Mariana Andrade Mousquer
BMBruna dos Santos Suñe Moraes
Bruna dos Santos Suñe Moraes
ASAlice Corrêa Santos
Alice Corrêa Santos
RSRafaela Pinto de Souza
Rafaela Pinto de Souza
MLMarcelo de Lima
Marcelo de Lima
CNCarlos Eduardo Wayne Nogueira
Carlos Eduardo Wayne Nogueira
Both pregnancy and obesity can influence the development of significant changes in the immune system, therefore, the present study aimed to evaluate the humoral immune response of pregnant overweight mares in response to a commercial vaccine. Thirty pregnant Crioulo mares were separated according to body condition score (BCS) into overweight mares (ECC≥7/9) and control mares (ECC = 5-6/9), yet in each group, animals were also separated into vaccinated and controls. The mares were vaccinated against EHV-1 in two doses with an interval of 21 days and collected monthly for five months for antibody evaluation. Both vaccinated groups had an increase in specific neutralizing antibodies after the vaccine, however, after the second dose, no increase in antibodies was observed in any of the groups. No difference was observed between vaccinated overweight and lean-control mares at any time point. Thus, this study demonstrated that obesity was not a factor that influenced the humoral immune response of pregnant mares.